Study to Evaluate the Efficacy, Safety, and Tolerability of E7070 in Metastatic Breast Cancer Patients
Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if E7070 is an efficacious, safe, and tolerable
treatment for patients with metastatic breast cancer who have failed, or could not tolerate,
prior treatments with an anthracycline, a taxane, and capecitabine.